PIA
AKAO

Piedmont Investment Advisors’s Achaogen Inc AKAO Stock Holding History

Piedmont Investment Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-545
Closed -$5K – 2839
2018
Q2 		$5K Buy
+545
New +$6.64K ﹤0.01% 2188

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Piedmont Investment Advisors's AKAO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Achaogen Inc (AKAO) in Q3 2018, closing a stake of 545 shares — an estimated $5K sold.

Piedmont Investment Advisors first reported a position in AKAO in Q2 2018 and held it in 1 quarter. The position peaked at $5K in Q2 2018. 92 funds tracked by Wall St. Rank hold AKAO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Achaogen Inc position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 545 Achaogen Inc shares in Q3 2018, an estimated $5K.
  • Piedmont Investment Advisors first reported a position in Achaogen Inc in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Achaogen Inc position peaked at $5K in Q2 2018.
  • 92 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.